SynthesisBMC infectious diseases2021

JAK-inhibitor and type I interferon ability to produce favorable clinical outcomes in COVID-19 patients: a systematic review and meta-analysis.

Lucas Walz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.